You are here:

pitolisant (Wakix)


in the absence of a submission from the holder of the marketing authorisation:

pitolisant (Wakix®) is not recommended for use within NHS Scotland.

Indication under review: Treatment of narcolepsy with or without cataplexy in adults

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: pitolisant (Wakix)
SMC Drug ID: 1229/17
Manufacturer: Lincoln Medical Limited
Indication: for the treatment of narcolepsy with or without cataplexy in adults.
BNF Category:
Sub Category: 4.5 Drugs used in the treatment of obesity
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 13 February 2017